Keyphrases
Polymorphism
100%
Serotonergic System
100%
Psychiatric Inpatients
100%
Antidepressant Therapy
100%
Variable number of Tandem Repeats
50%
5-hydroxytryptamine Receptors
50%
Selective Serotonin Reuptake Inhibitors
33%
Treatment Emergent
33%
5-HTTLPR/rs25531
33%
5-HTR2A
33%
Clinical Assessment
16%
Randomized Controlled Trial
16%
SNP
16%
Antidepressants
16%
Non-selective
16%
Adverse Effects
16%
Clinical Usefulness
16%
Depression Scale
16%
Symptom Scale
16%
Clinical Global Impression
16%
Serotonergic
16%
Naturalistic Setting
16%
Inhibitor Response
16%
2 Polymorphism
16%
Self-rating Scale
16%
Mirtazapine
16%
Serotonin Receptor Gene
16%
Serotonin Transporter Gene
16%
Clinical Outcomes
16%
Inhibitor Treatment
16%
Symptom Cluster
16%
Neuroscience
Serotonergic
100%
Antidepressant Therapy
100%
Serotonin Transporter
100%
Variable Number Tandem Repeat
75%
Intron
50%
5-HTTLPR
50%
Selective Serotonin Reuptake Inhibitor
50%
Clinical Assessment
25%
Randomized Controlled Trial
25%
Adverse Effect
25%
5-HT Receptor
25%
Antidepressant
25%
ABC Transporter Subfamily B
25%
Receptor
25%
Mirtazapine
25%
Biochemistry, Genetics and Molecular Biology
Serotonergic
100%
Serotonin Transporter
100%
Variable Number Tandem Repeat
75%
Intron
50%
5-HTTLPR
50%
Selective Serotonin Reuptake Inhibitor
50%
Single Nucleotide Polymorphism
25%
Clinical Study
25%
Randomized Controlled Trial
25%
Transporter Genes
25%
Allele
25%
Self Concept
25%
5-HT Receptor
25%
P-Glycoprotein
25%
Mirtazapine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Side Effect
100%
Serotonin Transporter
80%
Selective Serotonin Reuptake Inhibitor
40%
Randomized Controlled Trial
20%
Clinical Study
20%
P-Glycoprotein
20%
Mirtazapine
20%
Receptor
20%
Serotonin Receptor
20%